In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.32, marking a -3.36% move from the previous day. This change lagged the S&P 500's daily loss of 0.13%. On the other hand, ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

This second course of the Data-Driven Decision Making (DDDM) series provides a high-level overview of data analysis and visualization tools, preparing learners to discuss best practices and develop an ...

Soil microbiology is enjoying a period of challenge and discovery made possible by the availability of new approaches for characterizing microbial communities and for imaging the soil environment.

As Anthropic releases its most autonomous agents yet, a mounting clash with the military reveals the impossible choice between global scaling and a “safety first” ethos ...